微血管减压术治疗面肌痉挛的疗效与安全性：手术结果及并发症的回顾性分析
The Efficacy and Safety of Microvascular Decompression for Hemifacial Spasm: A Retrospective Analysis of Surgical Outcomes and Complications.
作者信息
Bekar Ahmet, Kuytu Turgut, Turkkan Alper, Altunyuva Oguz, Eser Ocak Pınar
机构信息
Bursa Uludag University School of Medicine, Department of Neurosurgery, Bursa, Turkey.
VM Medical Park Hospital, Department of Neurosurgery, Bursa, Turkey
出版信息
Turk Neurosurg. 2020;30(2):231-236. doi: 10.5137/1019-5149.JTN.27594-19.3.
AIM
To determine the efficacy and safety of microvascular decompression (MVD) for hemifacial spasm (HFS) by retrospectively reviewing our results.
MATERIAL AND METHODS
A total of 55 patients who underwent MVD in our clinic between 2003 and 2017 were retrospectively analyzed. Clinical outcome results, recurrence rates, and surgical complications were noted.
RESULTS
Thirty-six patients were female (65%). The mean age of the patients was 51.3 years. The mean duration of the complaint was 46.4 months. In 45 patients (82%), HFS was completely resolved within the first 6 months after the surgery. Five patients (9%) with recurrent symptoms were reoperated within the first year of the surgery. HFS symptoms of five patients (9%) completely ceased initially, but started again and reoperation was required due to failure of alternative treatments. Delayed facial nerve palsy and hearing loss were noted in one patient for each (2%). Cerebrospinal fluid leak was observed in two patients (4%). No mortality was observed in this series.
CONCLUSION
MVD is a safe and effective option for patients with HFS that is resistant to medical treatment.
目的
通过回顾我们的结果来确定微血管减压术（MVD）治疗面肌痉挛（HFS）的疗效和安全性。
材料与方法
回顾性分析2003年至2017年间在我院接受MVD治疗的55例患者。记录临床结果、复发率和手术并发症。
结果
36例患者为女性（65%）。患者的平均年龄为51.3岁。主诉的平均持续时间为46.4个月。45例患者（82%）在手术后的前6个月内HFS完全缓解。5例（9%）出现复发症状的患者在手术后的第一年内再次接受手术。5例患者（9%）的HFS症状最初完全停止，但后来再次出现，由于替代治疗失败而需要再次手术。各有1例患者（2%）出现迟发性面神经麻痹和听力丧失。2例患者（4%）出现脑脊液漏。本系列中未观察到死亡病例。
结论
对于药物治疗无效的HFS患者，MVD是一种安全有效的选择。
Zotero 插件